This study presents the first MCLIA kit for detecting T3-Ab and T4-Ab in human serum, revealing their potential as thyroid disorder biomarkers, particularly in cancer patients undergoing immune checkpoint blockade therapy, where they interfere with thyroid hormone measurements. The gene discussed is TG; the disease is cancer.